| Mr Doyle Miller Stone Iii, | |
|
12800 Garden Grove Blvd, F, Garden Grove, CA 92843-2008 | |
| (714) 620-8131 | |
| Not Available |
| Full Name | Mr Doyle Miller Stone Iii |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 12800 Garden Grove Blvd, Garden Grove, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144546417 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Doyle Miller Stone Iii, 12800 Garden Grove Blvd, F, Garden Grove, CA 92843-2008 Ph: (714) 620-8131 | Mr Doyle Miller Stone Iii, 12800 Garden Grove Blvd, F, Garden Grove, CA 92843-2008 Ph: (714) 620-8131 |
News Archive
In collaboration with the university hospitals of Hamburg, Hannover and Graz, as well as further partners, the Helmholtz-Zentrum Geesthacht will establish a Virtual Institute, whose focus will be set on degradable magnesium implants. One aim of the research association coordinated from Geesthacht is to develop first prototypes of orthopedic implants.
Relypsa, Inc., today announced the initiation of patient enrollment in a Phase 2, open-label titration clinical study of the company's lead drug candidate, RLY5016, in heart failure patients with chronic kidney disease. RLY5016 is a novel non-absorbed oral potassium binder intended to prevent and treat hyperkalemia, a serious condition characterized by elevated serum potassium levels.
A team of scientists from the University of California, Los Angeles, USA, recently conducted a survey investigating the association between availability of testing facilities and COVID-19-related behavioral aspects. Their findings reveal that testing unavailability independently influences certain COVID-19-related behaviors that may increase the risk of SARS-CoV-2 transmission.
Much like cancer, sepsis isn't simply one condition but rather many conditions that could benefit from different treatments, according to the results of a University of Pittsburgh School of Medicine study involving more than 60,000 patients.
Researchers have identified additional resistance mechanisms that could be targeted to improve the efficacy of irreversible epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small-cell lung cancer harbouring both EGFR and T790M mutations.
› Verified 7 days ago
Ms. Hieu Doan Pham, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 12371 Lewis St Ste 202, Garden Grove, CA 92840 Phone: 657-203-2472 | |
Julian Jesus Castillo, Counselor Medicare: Not Enrolled in Medicare Practice Location: 12141 Brookhurst St Ste 201, Garden Grove, CA 92840 Phone: 657-261-7140 Fax: 714-922-1032 | |
Caleb Andrew Weber, Counselor Medicare: Not Enrolled in Medicare Practice Location: 12755 Brookhurst St, Garden Grove, CA 92840 Phone: 714-638-8277 | |
Jasson Vega, Counselor Medicare: Not Enrolled in Medicare Practice Location: 12141 Brookhurst St, Garden Grove, CA 92840 Phone: 714-296-1934 | |
Ms. Linda Sue Cooley, CATC, RADI Counselor Medicare: Not Enrolled in Medicare Practice Location: 12800 Garden Grove Blvd Ste F, Garden Grove, CA 92843 Phone: 714-620-8131 | |
Robert Brian Braithwaite, Counselor Medicare: Not Enrolled in Medicare Practice Location: 12755 Brookhurst St, Ste114, Garden Grove, CA 92840 Phone: 714-638-8277 | |
Kelly Chau Quach, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 14411 Brookhurst St Ste D & E, Garden Grove, CA 92843 Phone: 714-548-7202 |